1029 related articles for article (PubMed ID: 15289372)
1. Antioxidant effects of statins via S-nitrosylation and activation of thioredoxin in endothelial cells: a novel vasculoprotective function of statins.
Haendeler J; Hoffmann J; Zeiher AM; Dimmeler S
Circulation; 2004 Aug; 110(7):856-61. PubMed ID: 15289372
[TBL] [Abstract][Full Text] [Related]
2. HMG-CoA reductase inhibitors reduce senescence and increase proliferation of endothelial progenitor cells via regulation of cell cycle regulatory genes.
Assmus B; Urbich C; Aicher A; Hofmann WK; Haendeler J; Rössig L; Spyridopoulos I; Zeiher AM; Dimmeler S
Circ Res; 2003 May; 92(9):1049-55. PubMed ID: 12676819
[TBL] [Abstract][Full Text] [Related]
3. Antioxidants inhibit nuclear export of telomerase reverse transcriptase and delay replicative senescence of endothelial cells.
Haendeler J; Hoffmann J; Diehl JF; Vasa M; Spyridopoulos I; Zeiher AM; Dimmeler S
Circ Res; 2004 Apr; 94(6):768-75. PubMed ID: 14963003
[TBL] [Abstract][Full Text] [Related]
4. Redox regulatory and anti-apoptotic functions of thioredoxin depend on S-nitrosylation at cysteine 69.
Haendeler J; Hoffmann J; Tischler V; Berk BC; Zeiher AM; Dimmeler S
Nat Cell Biol; 2002 Oct; 4(10):743-9. PubMed ID: 12244325
[TBL] [Abstract][Full Text] [Related]
5. Statin-stimulated nitric oxide release from endothelium.
Dobrucki LW; Kalinowski L; Dobrucki IT; Malinski T
Med Sci Monit; 2001; 7(4):622-7. PubMed ID: 11433186
[TBL] [Abstract][Full Text] [Related]
6. Statins enhance migratory capacity by upregulation of the telomere repeat-binding factor TRF2 in endothelial progenitor cells.
Spyridopoulos I; Haendeler J; Urbich C; Brummendorf TH; Oh H; Schneider MD; Zeiher AM; Dimmeler S
Circulation; 2004 Nov; 110(19):3136-42. PubMed ID: 15520325
[TBL] [Abstract][Full Text] [Related]
7. Statins activate AMP-activated protein kinase in vitro and in vivo.
Sun W; Lee TS; Zhu M; Gu C; Wang Y; Zhu Y; Shyy JY
Circulation; 2006 Dec; 114(24):2655-62. PubMed ID: 17116771
[TBL] [Abstract][Full Text] [Related]
8. Statins normalize vascular lysyl oxidase down-regulation induced by proatherogenic risk factors.
Rodríguez C; Alcudia JF; Martínez-González J; Guadall A; Raposo B; Sánchez-Gómez S; Badimon L
Cardiovasc Res; 2009 Aug; 83(3):595-603. PubMed ID: 19406911
[TBL] [Abstract][Full Text] [Related]
9. Statins inhibit cyclooxygenase-2 and matrix metalloproteinase-9 in human endothelial cells: anti-angiogenic actions possibly contributing to plaque stability.
Massaro M; Zampolli A; Scoditti E; Carluccio MA; Storelli C; Distante A; De Caterina R
Cardiovasc Res; 2010 May; 86(2):311-20. PubMed ID: 19946014
[TBL] [Abstract][Full Text] [Related]
10. Effects of the 3-hydroxy-3-methylglutaryl-CoA reductase inhibitors, atorvastatin and simvastatin, on the expression of endothelin-1 and endothelial nitric oxide synthase in vascular endothelial cells.
Hernández-Perera O; Pérez-Sala D; Navarro-Antolín J; Sánchez-Pascuala R; Hernández G; Díaz C; Lamas S
J Clin Invest; 1998 Jun; 101(12):2711-9. PubMed ID: 9637705
[TBL] [Abstract][Full Text] [Related]
11. Adverse balance of nitric oxide/peroxynitrite in the dysfunctional endothelium can be reversed by statins.
Heeba G; Hassan MK; Khalifa M; Malinski T
J Cardiovasc Pharmacol; 2007 Oct; 50(4):391-8. PubMed ID: 18049306
[TBL] [Abstract][Full Text] [Related]
12. Effects of long-term administration of HMG-CoA reductase inhibitor, atorvastatin, on stroke events and local cerebral blood flow in stroke-prone spontaneously hypertensive rats.
Tanaka N; Katayama Y; Katsumata T; Otori T; Nishiyama Y
Brain Res; 2007 Sep; 1169():125-32. PubMed ID: 17706949
[TBL] [Abstract][Full Text] [Related]
13. The transcription factor KLF2 mediates hepatic endothelial protection and paracrine endothelial-stellate cell deactivation induced by statins.
Marrone G; Russo L; Rosado E; Hide D; García-Cardeña G; García-Pagán JC; Bosch J; Gracia-Sancho J
J Hepatol; 2013 Jan; 58(1):98-103. PubMed ID: 22989565
[TBL] [Abstract][Full Text] [Related]
14. Statins blunt thrombin-induced down-regulation of endothelial nitric oxide synthase expression in human endothelial cells.
Eto M; Rathgeb L; Cosentino F; Kozai T; Lüscher TF
J Cardiovasc Pharmacol; 2006 May; 47(5):663-7. PubMed ID: 16775505
[TBL] [Abstract][Full Text] [Related]
15. Atorvastatin partially prevents an inflammatory barrier breakdown of cultured human brain endothelial cells at a pharmacologically relevant concentration.
Buttmann M; Lorenz A; Weishaupt A; Rieckmann P
J Neurochem; 2007 Aug; 102(4):1001-8. PubMed ID: 17442054
[TBL] [Abstract][Full Text] [Related]
16. Statins promote potent systemic antioxidant effects through specific inflammatory pathways.
Shishehbor MH; Brennan ML; Aviles RJ; Fu X; Penn MS; Sprecher DL; Hazen SL
Circulation; 2003 Jul; 108(4):426-31. PubMed ID: 12860913
[TBL] [Abstract][Full Text] [Related]
17. Alpha-adrenergic receptor-stimulated hypertrophy in adult rat ventricular myocytes is mediated via thioredoxin-1-sensitive oxidative modification of thiols on Ras.
Kuster GM; Pimentel DR; Adachi T; Ido Y; Brenner DA; Cohen RA; Liao R; Siwik DA; Colucci WS
Circulation; 2005 Mar; 111(9):1192-8. PubMed ID: 15723974
[TBL] [Abstract][Full Text] [Related]
18. Shear flow increases S-nitrosylation of proteins in endothelial cells.
Huang B; Chen SC; Wang DL
Cardiovasc Res; 2009 Aug; 83(3):536-46. PubMed ID: 19447776
[TBL] [Abstract][Full Text] [Related]
19. Class-specific pro-apoptotic effect of statins on human vascular endothelial cells.
Mück AO; Seeger H; Wallwiener D
Z Kardiol; 2004 May; 93(5):398-402. PubMed ID: 15160275
[TBL] [Abstract][Full Text] [Related]
20. Comparison of the effects of simvastatin versus atorvastatin on oxidative stress in patients with type 2 diabetes mellitus.
Su Y; Xu Y; Sun YM; Li J; Liu XM; Li YB; Liu GD; Bi S
J Cardiovasc Pharmacol; 2010 Jan; 55(1):21-5. PubMed ID: 19786892
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
